Effects of Prevotella copri on insulin, gut microbiota and bile acids

Gut Microbes. 2024 Jan-Dec;16(1):2340487. doi: 10.1080/19490976.2024.2340487. Epub 2024 Apr 16.

Abstract

Obesity is becoming a major global health problem in children that can cause diseases such as type 2 diabetes and metabolic disorders, which are closely related to the gut microbiota. However, the underlying mechanism remains unclear. In this study, a significant positive correlation was observed between Prevotella copri (P. copri) and obesity in children (p = 0.003). Next, the effect of P. copri on obesity was explored by using fecal microbiota transplantation (FMT) experiment. Transplantation of P. copri. increased serum levels of fasting blood glucose (p < 0.01), insulin (p < 0.01) and interleukin-1β (IL-1β) (p < 0.05) in high-fat diet (HFD)-induced obese mice, but not in normal mice. Characterization of the gut microbiota indicated that P. copri reduced the relative abundance of the Akkermansia genus in mice (p < 0.01). Further analysis on bile acids (BAs) revealed that P. copri increased the primary BAs and ursodeoxycholic acid (UDCA) in HFD-induced mice (p < 0.05). This study demonstrated for the first time that P. copri has a significant positive correlation with obesity in children, and can increase fasting blood glucose and insulin levels in HFD-fed obese mice, which are related to the abundance of Akkermansia genus and bile acids.

Keywords: Obesity; bile acids; gut microbiota; insulin; prevotella copri.

MeSH terms

  • Animals
  • Bile Acids and Salts / pharmacology
  • Blood Glucose
  • Child
  • Diabetes Mellitus, Type 2*
  • Diet, High-Fat / adverse effects
  • Gastrointestinal Microbiome*
  • Humans
  • Insulin
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Pediatric Obesity*
  • Prevotella*

Substances

  • Insulin
  • Bile Acids and Salts
  • Blood Glucose

Supplementary concepts

  • Prevotella copri

Grants and funding

This study was supported by the National Natural Science Foundation of China (32102578, U22A20515), National Key R&D Program of China (2023YFD1302300, 2023YFD1301200), Changsha Natural Science Foundation (kq2208092), and the Hunan Provincial Health Commission (C202306017634).